Cai Xiaoqing, Whitfield Timothy, Moreno Amira Y, Grant Yanabel, Hixon Mark S, Koob George F, Janda Kim D
Departments of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, The Worm Institute of Research and Medicine, The Scripps Research Institute , 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Mol Pharm. 2013 Nov 4;10(11):4176-84. doi: 10.1021/mp400214w. Epub 2013 Oct 4.
Judicious hapten design has been shown to be of importance when trying to generate a viable vaccine against a drug of abuse. Hapten design has typically been predicated upon faithfully emulating the unique chemical architecture that each drug presents. However, the need for drug-hapten congruency may also compromise vaccine immunogenicity if the drug-hapten conjugate possesses chemical epitope instability. There has been no systematic study on the impact of hapten stability as it relates to vaccine immunogenicity. As a starting point, we have probed the stability of a series of cocaine haptens through varying several of its structural elements, including functionality at the C2-position, the nature of the linker, and its site of attachment. Accordingly, a hydrolytic stability profile of four cocaine haptens (GNNA, GNNS, GNE, and GNC) was produced, and these results were compared through each hapten's immunological properties, which were generated via active vaccination. From this group of four, three of the haptens, GNE, GNNA, and GNC, were further examined in an animal behavioral model, and findings here were again measured in relationship to hapten stability. We demonstrate a corresponding relationship between the half-life of the hapten and its immunogenicity, wherein haptens presenting a fully representative cocaine framework elicited higher concentrations of cocaine-specific IgG in sera and also conferred better protection against cocaine-induced locomotor activity. Our results indicate that hapten half-life plays an important role in vaccine immunogenicity and this in turn can impact animal behavioral effects when challenged with a drug of abuse.
在试图研发一种针对滥用药物的可行疫苗时,合理的半抗原设计已被证明至关重要。半抗原设计通常基于忠实地模仿每种药物呈现的独特化学结构。然而,如果药物 - 半抗原偶联物具有化学表位不稳定性,那么对药物 - 半抗原一致性的需求也可能会损害疫苗的免疫原性。关于半抗原稳定性与疫苗免疫原性之间关系,尚未有系统的研究。作为起点,我们通过改变可卡因半抗原的几个结构元素,包括C2位的官能团、连接子的性质及其连接位点,来探究一系列可卡因半抗原的稳定性。相应地,生成了四种可卡因半抗原(GNNA、GNNS、GNE和GNC)的水解稳定性概况,并通过每种半抗原的免疫特性进行比较,这些免疫特性是通过主动免疫产生的。在这四种半抗原中,其中三种半抗原GNE、GNNA和GNC在动物行为模型中进一步研究,并且在此处的发现再次与半抗原稳定性相关联进行测量。我们证明了半抗原的半衰期与其免疫原性之间存在相应关系,其中呈现完全代表性可卡因框架的半抗原在血清中引发更高浓度的可卡因特异性IgG,并且还对可卡因诱导的运动活性提供了更好的保护。我们的结果表明,半抗原半衰期在疫苗免疫原性中起重要作用,而这反过来又会在受到滥用药物挑战时影响动物行为效应。